| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/06/2023 | 291.64% | BTIG | → $15 | Assumes | → Buy |
| 10/02/2023 | 213.32% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 09/12/2023 | 291.64% | B of A Securities | $13 → $15 | Maintains | Buy |
| 08/31/2023 | 213.32% | HC Wainwright & Co. | → $12 | Initiates Coverage On | → Buy |
| 02/07/2023 | 422.19% | BTIG | $24 → $20 | Maintains | Buy |
| 05/24/2022 | 291.64% | Cantor Fitzgerald | → $15 | Initiates Coverage On | → Overweight |
| 05/26/2020 | 448.3% | B of A Securities | → $21 | Initiates Coverage On | → Buy |
| 05/26/2020 | 526.63% | Jefferies | → $24 | Initiates Coverage On | → Buy |
What is the target price for Lyra Therapeutics (LYRA)?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by BTIG on October 6, 2023. The analyst firm set a price target for $15.00 expecting LYRA to rise to within 12 months (a possible 291.64% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lyra Therapeutics (LYRA)?
The latest analyst rating for Lyra Therapeutics (NASDAQ: LYRA) was provided by BTIG, and Lyra Therapeutics their buy rating.
When is the next analyst rating going to be posted or updated for Lyra Therapeutics (LYRA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lyra Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lyra Therapeutics was filed on October 6, 2023 so you should expect the next rating to be made available sometime around October 6, 2024.
Is the Analyst Rating Lyra Therapeutics (LYRA) correct?
While ratings are subjective and will change, the latest Lyra Therapeutics (LYRA) rating was a with a price target of $0.00 to $15.00. The current price Lyra Therapeutics (LYRA) is trading at is $3.83, which is within the analyst's predicted range.